Alnylam Pharmaceuticals
ALNY
#447
Rank
A$78.96 B
Marketcap
A$597.68
Share price
-2.07%
Change (1 day)
54.27%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company